Antony D. Loebel | Psychiatrist.com

Letter to the Editor

Dr. Addington and Colleagues reply to Methodological Issues in a Comparative Study of Ziprasidone and Risperidone Methodological Issues in a Comparative Study of Ziprasidone and Risperidone

Original Research

Long-Term Safety and Efficacy of Ziprasidone in Subpopulations of Patients With Bipolar Mania

Original Research

Ziprasidone in Treatment-Resistant Schizophrenia: A 52-Week, Open-Label Continuation Study

Original Research

Change in Framingham Risk Score in Patients With Schizophrenia: A Post Hoc Analysis of a Randomized, Double-Blind, 6-Week Trial of Ziprasidone and Olanzapine